IRulya Therapeutics, Inc. (IRLA)
32.95
+1.33
(+4.21%)
USD |
NASDAQ |
Oct 30, 16:00
33.50
+0.55
(+1.67%)
After-Hours: 20:00
IRulya Therapeutics Free Cash Flow : -47.00M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -47.00M |
| March 31, 2026 | -39.66M |
| December 31, 2025 | -41.78M |
| September 30, 2025 | -38.98M |
| June 30, 2025 | -36.28M |
| March 31, 2025 | -33.52M |
| December 31, 2024 | -32.16M |
| September 30, 2024 | -30.58M |
| June 30, 2024 | -28.09M |
| March 31, 2024 | -23.14M |
| December 31, 2023 | -18.45M |
| September 30, 2023 | -18.26M |
| June 30, 2023 | -20.19M |
| March 31, 2023 | -31.78M |
| Date | Value |
|---|---|
| December 31, 2022 | -44.17M |
| September 30, 2022 | -52.72M |
| June 30, 2022 | -63.32M |
| March 31, 2022 | -65.56M |
| December 31, 2021 | -63.11M |
| September 30, 2021 | -61.94M |
| June 30, 2021 | -56.98M |
| March 31, 2021 | -53.73M |
| December 31, 2020 | -50.87M |
| September 30, 2020 | -48.54M |
| June 30, 2020 | -44.97M |
| March 31, 2020 | -36.85M |
| December 31, 2019 | -33.33M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Korsana Biosciences, Inc. | -4.517M |
| PepGen Inc. | -69.46M |
| Q32 Bio, Inc. | -19.83M |
| Bridgebio Oncology Therapeutics, Inc. | -193.82M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.89M |
| Cash from Investing (Quarterly) | 8.001M |
| Cash from Financing (Quarterly) | 108.93M |
| Free Cash Flow Per Share (Quarterly) | -3.080 |
| Free Cash Flow to Equity (Quarterly) | -18.48M |
| Free Cash Flow to Firm (Quarterly) | -18.89M |
| Free Cash Flow Yield | -79.90% |